
More Americans will soon be paying less for their insulin. Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70% and cap out-of-pocket costs at $35 a month. “While the current health care system provides access to insulin for most people with diabetes, it still does… read on > read on >